Sign in

CIK 0000818686 · Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972 (3) 914-8213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,242,786
in 10 filings, $10.6M under 10b5-1 plans

Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-03-05 Drape Eric Executive VP Global Operations Option exercise · Restricted Share Units 10b5-1 −22,576 22,576
2024-03-05 Drape Eric Executive VP Global Operations Option exercise · Restricted Share Units 10b5-1 −55,226 0
2024-03-05 Daniell Richard Exec. VP, European Commercial Option exercise 10b5-1 +22,576 92,346
2024-03-05 Daniell Richard Exec. VP, European Commercial Sale 10b5-1 −22,576 $13.52 $305K 69,770
2024-03-05 Daniell Richard Exec. VP, European Commercial Option exercise 10b5-1 +55,226 124,996
2024-03-05 Daniell Richard Exec. VP, European Commercial Sale 10b5-1 −26,053 $13.52 $352K 98,943
2024-03-05 Daniell Richard Exec. VP, European Commercial Option exercise · Restricted Share Units 10b5-1 −22,576 22,576
2024-03-05 Daniell Richard Exec. VP, European Commercial Option exercise · Restricted Share Units 10b5-1 −55,226 0
2024-03-05 Conway Vikki L See "Remarks" Option exercise 10b5-1 +4,954 16,646
2024-03-05 Conway Vikki L See "Remarks" Sale 10b5-1 −1,427 $13.52 $19K 15,219
2024-03-05 Conway Vikki L See "Remarks" Option exercise · Restricted Share Units 10b5-1 −4,954 4,957
2024-03-05 Sabag Mark EVP, International Markets Option exercise +23,764 424,457
2024-03-05 Sabag Mark EVP, International Markets Option exercise +58,133 482,590
2024-03-05 Sabag Mark EVP, International Markets Sale −100,000 $13.52 $1.4M 382,590
2024-03-05 Sabag Mark EVP, International Markets Option exercise · Restricted Share Units −23,764 23,765
2024-03-05 Sabag Mark EVP, International Markets Option exercise · Restricted Share Units −58,133 0
2024-03-05 Weiss Amir Chief Accounting Officer Option exercise +3,564 33,314
2024-03-05 Weiss Amir Chief Accounting Officer Option exercise · Restricted Share Units −3,564 3,566
2024-03-04 McAvoy David R. EVP, Chief Legal Officer Grant or award · Restricted Share Units +66,964 66,964
2024-03-04 Conway Vikki L See "Remarks" Sale 10b5-1 −1,490 $13.37 $20K 6,617

Page 22 of 76 · 1,517 trades